Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fluorouracil
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : CBCC Global
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Cytotoxic Drug
Upfront Cash : Inapplicable
October 15, 2021
Lead Product(s) : Fluorouracil
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : CBCC Global
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Diclofenac Sodium
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Novum Pharmaceutical Research Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 01, 2019
Lead Product(s) : Diclofenac Sodium
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Novum Pharmaceutical Research Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ketoconazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Novum Pharmaceutical Research Services | ACM Global Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 31, 2019
Lead Product(s) : Ketoconazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Novum Pharmaceutical Research Services | ACM Global Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Permethrin
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Novum Pharmaceutical Research Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 07, 2017
Lead Product(s) : Permethrin
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Novum Pharmaceutical Research Services
Deal Size : Inapplicable
Deal Type : Inapplicable